Use of azathioprine for graft-vs-host disease is the major risk for development of secondary malignancies after haematopoietic stem cell transplantation: A nationwide population-based study
S. H. Chien, C. J. Liu, Y. C. Hong, C. J. Teng, Y. W. Hu, C. C. Shen, F. C. Ku, S. C. Chen, C. M. Yeh, T. J. Chiou, J. P. Gau, C. H. Tzeng
研究成果: 雜誌貢獻 › 文章 › 同行評審
18
引文
斯高帕斯(Scopus)